Angewandte Chemie,
Journal Year:
2024,
Volume and Issue:
136(26)
Published: April 19, 2024
Abstract
Fluorescence
sensing
is
crucial
to
studying
biological
processes
and
diagnosing
diseases,
especially
in
the
second
near‐infrared
(NIR‐II)
window
with
reduced
background
signals.
However,
it's
still
a
great
challenge
construct
“off‐on”
sensors
when
wavelength
extends
into
NIR‐II
region
obtain
higher
imaging
contrast,
mainly
due
difficult
synthesis
of
spectral
overlapped
quencher.
Here,
we
present
new
fluorescence
quenching
strategy,
which
utilizes
steric
hindrance
quencher
(SHQ)
tune
molecular
packing
state
fluorophores
suppress
emission
signal.
Density
functional
theory
(DFT)
calculations
further
reveal
that
large
SHQs
can
competitively
pack
prevent
their
self‐aggregation.
Based
on
this
mechanism,
novel
activatable
method
achieved
via
bio‐analyte
responsive
invalidation
SHQ,
namely
Steric
Hindrance
Invalidation
geNerated
Emission
(SHINE)
strategy.
As
proof
concept,
ClO
−
‐sensitive
SHQ
lead
bright
signal
release
epileptic
mouse
hippocampus
under
skull
high
photon
scattering
brain
tissue,
providing
real‐time
visualization
generation
process
living
mice.
Advanced Science,
Journal Year:
2023,
Volume and Issue:
10(13)
Published: Feb. 23, 2023
Although
the
curative
effect
of
hematological
malignancies
has
been
improved
in
recent
years,
relapse
or
drug
resistance
will
eventually
recur.
Furthermore,
microenvironment
disorder
is
an
important
mechanism
pathogenesis
malignancies.
Immunogenic
cell
death
(ICD)
a
unique
regulated
(RCD)
that
triggers
intact
antigen-specific
adaptive
immune
response
by
firing
set
danger
signals
damage-associated
molecular
patterns
(DAMPs),
which
immunotherapeutic
modality
with
potential
for
treatment
This
review
summarizes
existing
knowledge
about
induction
ICD
and
current
research
on
combining
inducers
other
strategies
Small Methods,
Journal Year:
2023,
Volume and Issue:
7(5)
Published: Feb. 19, 2023
Multifunctional
phototheranostics
that
integrate
several
diagnostic
and
therapeutic
strategies
into
one
platform
hold
great
promise
for
precision
medicine.
However,
it
is
really
difficult
molecule
to
possess
multimodality
optical
imaging
therapy
properties
all
functions
are
in
the
optimized
mode
because
absorbed
photoenergy
fixed.
Herein,
a
smart
one-for-all
nanoagent
photophysical
energy
transformation
processes
can
be
facilely
tuned
by
external
light
stimuli
developed
precise
multifunctional
image-guided
therapy.
A
dithienylethene-based
designed
synthesized
has
two
light-switchable
forms.
In
ring-closed
form,
most
of
dissipates
via
nonradiative
thermal
deactivation
photoacoustic
(PA)
imaging.
ring-open
possesses
obvious
aggregation-induced
emission
features
with
excellent
fluorescence
photodynamic
properties.
vivo
experiments
demonstrate
preoperative
PA
help
delineate
tumors
high-contrast
manner,
intraoperative
able
sensitively
detect
tiny
residual
tumors.
Furthermore,
induce
immunogenic
cell
death
elicit
antitumor
immunity
significantly
suppress
solid
This
work
develops
agent
related
phototheranostic
light-driven
structure
switch,
which
promising
biomedical
applications.
Angewandte Chemie International Edition,
Journal Year:
2023,
Volume and Issue:
63(4)
Published: Nov. 29, 2023
Afterglow
luminescence
imaging
probes,
with
long-lived
emission
after
cessation
of
light
excitation,
have
drawn
increasing
attention
in
biomedical
field
owing
to
their
elimination
autofluorescence.
However,
current
afterglow
agents
always
suffer
from
an
unsatisfactory
signal
intensity
and
complex
systems
consisting
multiple
ingredients.
To
address
these
issues,
this
study
reports
a
near-infrared
(NIR)
luminophore
(TPP-DO)
by
chemical
conjugation
substrate
photosensitizer
acting
as
both
initiator
energy
relay
unit
into
single
molecule,
resulting
intramolecular
transfer
process
improve
the
brightness.
The
constructed
TPP-DO
NPs
emit
strong
NIR
up
10
JACS Au,
Journal Year:
2023,
Volume and Issue:
3(5), P. 1507 - 1520
Published: May 9, 2023
Sonodynamic
therapy
(SDT)
holds
great
promise
to
be
applied
for
cancer
in
clinical
settings.
However,
its
poor
therapeutic
efficacy
has
limited
applications
owing
the
apoptosis-resistant
mechanism
of
cells.
Moreover,
hypoxic
and
immunosuppressive
tumor
microenvironment
(TME)
also
weakens
immunotherapy
solid
tumors.
Therefore,
reversing
TME
remains
a
formidable
challenge.
To
circumvent
these
critical
issues,
we
developed
an
ultrasound-augmented
strategy
regulate
by
utilizing
HMME-based
liposomal
nanosystem
(HB
liposomes),
which
can
synergistically
promote
induction
ferroptosis/apoptosis/immunogenic
cell
death
(ICD)
initiate
reprograming
TME.
The
RNA
sequencing
analysis
demonstrated
that
apoptosis,
hypoxia
factors,
redox-related
pathways
were
modulated
during
treatment
with
HB
liposomes
under
ultrasound
irradiation.
vivo
photoacoustic
imaging
experiment
showed
enhanced
oxygen
production
TME,
alleviated
hypoxia,
helped
overcome
tumors,
consequently
improving
SDT
efficiency.
More
importantly,
extensively
induced
ICD,
resulting
T-cell
recruitment
infiltration,
normalizes
facilitates
antitumor
immune
responses.
Meanwhile,
system
combined
PD1
checkpoint
inhibitor
achieves
superior
synergistic
inhibition.
Both
vitro
results
indicate
act
as
sonodynamic
adjuvant
is
able
induce
ferroptosis/apoptosis/ICD
via
generated
lipid-reactive
oxide
species
reprogram
due
ICD
induction.
This
integrating
supply,
reactive
generation,
excellent
effective
modulation
efficient
therapy.
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
63(11)
Published: Jan. 22, 2024
Afterglow
imaging
holds
great
promise
for
ultrasensitive
bioimaging
due
to
its
elimination
of
autofluorescence.
Self-sustaining
afterglow
molecules
(SAMs),
which
enable
all-in-one
photon
sensitization,
chemical
defect
formation
and
generation,
possess
a
simplified,
reproducible,
efficient
superiority
over
commonly
used
multi-component
systems.
However,
there
is
lack
SAMs,
particularly
those
with
much
brighter
near-infrared
(NIR)
emission
structural
flexibility
building
high-contrast
activatable
probes.
To
address
these
issues,
this
study
the
first
time
reports
methylene
blue
derivative-based
self-sustaining
agent
(SAN-M)
NIR
chemiluminescence
peaking
at
710
nm.
By
leveraging
tunability,
an
nanoprobe
(SAN-MO)
customized
simultaneously
fluoro-photoacoustic
peroxynitrite
(ONOO
Theranostics,
Journal Year:
2024,
Volume and Issue:
14(6), P. 2464 - 2488
Published: Jan. 1, 2024
Cancer
has
remained
a
formidable
challenge
in
medicine
and
claimed
an
enormous
number
of
lives
worldwide.Theranostics,
combining
diagnostic
methods
with
personalized
therapeutic
approaches,
shows
huge
potential
to
advance
the
battle
against
cancer.This
review
aims
provide
overview
theranostics
oncology:
exploring
its
history,
current
advances,
challenges,
prospects.We
present
fundamental
evolution
from
radiotherapeutics,
cellular
therapeutics,
nanotherapeutics,
showcasing
critical
milestones
last
decade.From
early
concept
targeted
drug
delivery
emergence
medicine,
benefited
advances
imaging
technologies,
molecular
biology,
nanomedicine.Furthermore,
we
emphasize
pertinent
illustrations
that
revolutionary
strategies
cancer
management
enhance
accuracy
therapies
customized
for
individual
patients,
thereby
facilitating
implementation
medicine.Finally,
describe
future
perspectives
on
emerging
topics,
field.
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
63(37)
Published: May 22, 2024
Though
platinum
(Pt)-based
complexes
have
been
recently
exploited
as
immunogenic
cell
death
(ICD)
inducers
for
activating
immunotherapy,
the
effective
activation
of
sufficient
immune
responses
with
minimal
side
effects
in
deep-seated
tumors
remains
a
formidable
challenge.
Herein,
we
propose
first
example
near-infrared
(NIR)
light-activated
and
lysosomal
targeted
Pt(II)
metallacycle
(1)
supramolecular
ICD
inducer.
1
synergistically
potentiates
immunomodulatory
response
via
multiple-regulated
approaches,
involving
NIR
light
excitation,
boosted
reactive
oxygen
species
(ROS)
generation,
good
selectivity
between
normal
tumor
cells,
enhanced
penetration/retention
capabilities.
Specifically,
has
excellent
depth-activated
ROS
production
(~7
mm),
accompanied
by
strong
anti-diffusion
anti-ROS
quenching
ability.
In
vitro
experiments
demonstrate
that
exhibits
significant
cellular
uptake
generation
cells
well
respective
multicellular
spheroids.
Based
on
these
advantages,
induces
more
efficient
an
ultralow
dose
(i.e.,
5
μM)
compared
clinical
inducer-oxaliplatin
(300
μM).
vivo,
vaccination
further
serves
potent
inducer
through
eliciting
CD8
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 8, 2024
Abstract
Activatable
afterglow
luminescence
nanoprobes
enabling
switched
“off-on”
signals
in
response
to
biomarkers
have
recently
emerged
achieve
reduced
unspecific
and
improved
imaging
fidelity.
However,
such
always
use
a
biomarker-interrupted
energy
transfer
obtain
an
activatable
signal,
which
necessitates
strict
distance
requisition
between
donor
acceptor
moiety
(<10
nm)
hence
induces
low
efficiency
non-feasibility.
Herein,
we
report
organic
upconversion
cocktail
nanoparticles
(ALCNs)
that
instead
utilize
acidity-manipulated
singlet
oxygen
(
1
O
2
)
with
enlarged
thus
possess
more
flexibility
signal.
After
vitro
validation
of
acidity-activated
luminescence,
ALCNs
vivo
4T1-xenograft
subcutaneous
tumors
female
mice
orthotopic
liver
male
high
signal-to-noise
ratio
(SNR).
As
representative
targeting
trial,
Bio-ALCNs
biotin
modification
prove
the
enhanced
ability,
sensitivity,
specificity
for
pulmonary
metastasis
tumor
via
systemic
administration
mice,
also
implies
potential
broad
utility
diverse
design
flexibility.
Therefore,
this
study
provides
innovative
general
approach
better
performance
than
fluorescence
imaging.
Aggregate,
Journal Year:
2024,
Volume and Issue:
5(3)
Published: Jan. 22, 2024
Abstract
The
induction
of
regulated
cell
death
(RCD)
through
photo/ultrasound
sensitization
therapeutic
agents
has
gained
significant
attention
as
a
vital
approach
to
combat
drug
resistance
in
tumors.
Aggregation‐induced
emission
(AIE)
generate
reactive
oxygen
species
activation,
which
can
synergize
with
RCD
inducers
or
directly
induce
RCD,
ultimately
resulting
the
tumor
cells.
presented
comprehensive
review
delves
into
recent
advancements
AIE
designed
trigger
inducers,
encompassing
apoptosis,
necroptosis,
pyroptosis,
immunogenic
death,
autophagy,
ferroptosis,
and
cuproptosis.
Additionally,
intricate
regulatory
mechanisms
activatory‐AIE
therapeutics
influence
distinct
pathways
are
examined.
A
forward‐looking
perspective
on
future
developments
pertinent
challenges
within
this
exciting
realm
is
presented,
anticipating
continued
evolution
activatable
transformative
enhance
therapy.